相关产品推荐更多 >
万千商家帮你免费找货
0 人在求购买到急需产品
- 详细信息
- 文献和实验
- 技术资料
- 英文名:
SNU-387
- 库存:
现货库存
- 供应商:
南京万木春
- 肿瘤类型:
/
- 细胞类型:
/
- 品系:
/
- 组织来源:
/
- 相关疾病:
/SNU-387人肝癌细胞
- 物种来源:
/
- 免疫类型:
/
- 细胞形态:
/
- 是否是肿瘤细胞:
/
- 器官来源:
SNU-387人肝癌细胞
- 运输方式:
常温/干冰
- 年限:
三代内
- 生长状态:
贴壁生长
人肝癌细胞SNU-387
| 种属 | 人 |
| 别称 | SNU387; NCI-SNU-387 |
| 组织来源 | 肝脏 |
| 疾病 | 多形性肝细胞癌 |
| 传代比例/细胞消化 | 1:2传代 ,消化2-3分钟 |
| 完全培养基配置 | RPMI1640培养基;10%胎牛血清;1%双抗 |
| 简介 | SNU-387 于 1990 年由 J.-G. Park 及其同事取自一名韩国患者的原发性肝细胞癌 ,该患者接受了脂质体联合多柔比 星和丝裂霉素-C 的经导管动脉栓塞治疗 |
| 形态 | 上皮细胞样 |
| 生长特征 | 贴壁生长 |
| 倍增时间 | ~22h |
| STR | Amelogenin: X CSF1PO: 13,14 D13S317: 12 D16S539: 9 D5S818: 10,12 D7S820: 8,10 THO1: 7 TPOX: 8,9 vWA: 14,16 |
| 培养条件 | 气相:空气 ,95% ;二氧化碳 ,5%。 温度:37摄氏度 ,培养箱湿度为70%-80%。 |
| 冻存条件 | 冻存液:90%FBS ,DMSO 10%, 或使用非程序冻存液:官网货号JY-H040 |
| 保藏机构 | ATCC; CRL-2237 |
| 产品使用 | 仅限于科学研究 ,不可作为动物或人类疾病的治疗产品使用。 |
were set as the otPservation group, and 90 healthy people who passed the physical examination were set as the control group. The levels of serum SPARC, DFR and Gal-3 of the two group were detected and
Background: Hospitals face mounting pressure to reduce unplanned utilization amid rising healthcare demands from an aging population. The Case management for At-Risk patients in the Emergency Department (CARED) program is among the first ED transitional care strategies to focus on both frail older adults and Emergency Department (ED) re-attenders to reduce acute hospital utilization. This study aims to evaluate the effectiveness of the CARED program in reducing hospital (re)admissions and ED re-attendances within 30- and 60-days post-discharge.
Methods: A retrospective, propensity-matched study was conducted from April 2022 to July 2023 in the ED of Ng Teng Fong General Hospital in Singapore. The CARED program identifies and enrols at-risk patients i.e., frail older adults and patients who re-attend the ED within 30 days of hospital discharge, for a geriatric assessment. This is followed by multidisciplinary team care, discharge planning and right siting of care from the ED to community-based services by ED case managers. The primary outcomes were hospital (re)admissions and ED re-attendances within 30- and 60-days post-discharge. Secondary outcomes were cost avoidance and bed occupancy days from reduced acute hospital usage.
风险提示:丁香通仅作为第三方平台,为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全,合理判断,谨慎选购商品,商家和用户对交易行为负责。对于医疗器械类产品,请先查证核实企业经营资质和医疗器械产品注册证情况。
文献和实验 were set as the otPservation group, and 90 healthy people who passed the physical examination were set as the control group. The levels of serum SPARC, DFR and Gal-3 of the two group were detected and
技术资料






